Literature DB >> 1362929

Phenobarbital and dexamethasone induce expression of cytochrome P-450 genes from subfamilies IIB, IIC, and IIIA in mouse liver.

L Corcos1.   

Abstract

Phenobarbital (PB) and dexamethasone (DEX) induce several liver-specific cytochrome P-450 mRNAs in rats. We examined the induction of P-450 mRNAs from families IIB, IIC, and IIIA by PB and DEX in six inbred mouse strains. P-450IIB1-related mRNA species were induced 3- to 13-fold by PB and 3- to 15-fold by DEX in all animals. P-450IIC6-related mRNA species were induced 3- to 7-fold by PB in males and females, and up to 5-fold by DEX in most males but not in female mice, in which DEX was inactive. P-450IIIA-related mRNA species were induced 2- to 7-fold by PB and 2- to 20-fold by DEX in all animals of either sex. In DBA/2J female mice, both inducers triggered a comparable early response (4 hr) at a low dose (10 mg/kg) for all three gene subfamilies, the maximum being reached between 8 and 18 hr of treatment with 100 mg/kg. Under the optimal induction conditions, coadministration of PB and DEX did not lead to any further increase in the responses. These results demonstrate the existence of analogies, as well as striking differences in the inductive effects of PB and DEX between rats and mice. They also indicate the possible involvement of these inducers in related inductive pathways for three cytochrome P-450 gene subfamilies in mouse liver.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362929

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

Review 1.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

2.  Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.

Authors:  Zhihua Liu; Lei Li; Hong Wu; Jing Hu; Jun Ma; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2014-11-19       Impact factor: 3.922

3.  Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

4.  Genetic analysis of the phenobarbital regulation of the cytochrome P-450 2b-9 and aldehyde dehydrogenase type 2 mRNAs in mouse liver.

Authors:  M Damon; A Fautrel; A Guillouzo; L Corcos
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

5.  Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure.

Authors:  Michelle A Rudek; Cathy Y Chang; Kenneth Steadman; Michael D Johnson; Naveen Desai; John F Deeken
Journal:  Cancer Chemother Pharmacol       Date:  2014-02-02       Impact factor: 3.333

6.  A method for determining δ-aminolevulinic acid synthase activity in homogenized cells and tissues.

Authors:  Hector A Bergonia; Michael R Franklin; James P Kushner; John D Phillips
Journal:  Clin Biochem       Date:  2015-05-08       Impact factor: 3.281

7.  Preclinical assessment of the interactions between the antiretroviral drugs, ritonavir and efavirenz, and the tyrosine kinase inhibitor erlotinib.

Authors:  John F Deeken; Jan H Beumer; Nicole M Anders; Teresia Wanjiku; Milan Rusnak; Michelle A Rudek
Journal:  Cancer Chemother Pharmacol       Date:  2015-09-02       Impact factor: 3.333

Review 8.  Possible drug-drug interaction in dogs and cats resulted from alteration in drug metabolism: A mini review.

Authors:  Kazuaki Sasaki; Minoru Shimoda
Journal:  J Adv Res       Date:  2015-02-24       Impact factor: 10.479

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.